{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.56","meta":{"versionId":"6","lastUpdated":"2015-07-14T01:00:00.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.56","version":"20150714","name":"HER2 NEU test","status":"active","date":"2015-07-14T01:00:00-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"444711007","display":"Measurement of total human epidermal growth factor receptor 2 using reverse phase protein microarray technique (procedure)"}]}]},"expansion":{"identifier":"urn:uuid:08fb6b82-c111-4393-97d0-2651655d355f","timestamp":"2022-06-10T08:16:28-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"444711007","display":"Measurement of total human epidermal growth factor receptor 2 using reverse phase protein microarray technique (procedure)"}]}}